{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:22:31Z","timestamp":1794853351346,"version":"4.9.1"},"reference-count":27,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["INVES19041ALVA"],"award-info":[{"award-number":["INVES19041ALVA"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["OncoImmunology"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/2162402x.2023.2197370","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T23:00:33Z","timestamp":1680735633000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic"],"prefix":"10.1080","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5969-9181","authenticated-orcid":false,"given":"Maite","family":"Alvarez","sequence":"first","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Molina","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saray","family":"Garasa","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Ochoa","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E","family":"Rodriguez-Ruiz","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Universidad de Navarra","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Gomis","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"Cirella","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Olivera","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Glez-Vaz","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Gonzalez-Gomariz","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"carlos","family":"luri-Rey","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"arantza","family":"azpilikueta","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elixabet","family":"Bola\u00f1os","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Teijeira","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Berraondo","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Quintero","sequence":"additional","affiliation":[{"name":"Highlight Therapeutics","place":["Valencia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1360-348X","authenticated-orcid":false,"given":"Ignacio","family":"Melero","sequence":"additional","affiliation":[{"name":"CIMA, Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"Navarra Institute for Health Research (IdiSNA)","place":["Pamplona, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC)","place":["Madrid, Spain"]},{"name":"Cl\u00ednica Universidad de Navarra","place":["Pamplona, Spain"]},{"name":"University of Oxford","place":["Oxford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00507-y"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3642"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00343"},{"key":"e_1_3_4_5_1","article-title":"Idera pharmaceuticals announces results from illuminate-301 trial of tilsotolimod + ipilimumab in anti-PD-1 refractory advanced melanoma","author":"Conwell J","year":"2021","unstructured":"Conwell J, Kirby J. Idera pharmaceuticals announces results from illuminate-301 trial of tilsotolimod + ipilimumab in anti-PD-1 refractory advanced melanoma. Aceragen. 2021.","journal-title":"Aceragen"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1109"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0577"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0829-0"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211437"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2994"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02660"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201445"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.08.016"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01510-7"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.07.004"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb0152"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0568-2"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002953"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005011"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb0391"},{"key":"e_1_3_4_21_1","volume-title":"Efficacy of intratumoral BO-112 with systemic pembrolizumab in patients with advanced melanoma refractory to anti-PD-1-based therapy: final results of SPOTLIGHT203 phase 2 study 2022","author":"M\u00e1rquez-Rodas I","year":"2022","unstructured":"M\u00e1rquez-Rodas I, Dutriaux C, Saiag P, Merino, 2022. Efficacy of intratumoral BO-112 with systemic pembrolizumab in patients with advanced melanoma refractory to anti-PD-1-based therapy: final results of SPOTLIGHT203 phase 2 study 2022. New Orleans:AACR"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164206"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003586"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.10.006"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2019"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0210-z"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01132-2"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn8097"}],"container-title":["OncoImmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/2162402X.2023.2197370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:42:09Z","timestamp":1780418529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/2162402X.2023.2197370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/2162402X.2023.2197370"],"URL":"https:\/\/doi.org\/10.1080\/2162402x.2023.2197370","relation":{},"ISSN":["2162-402X"],"issn-type":[{"value":"2162-402X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2197370"}}